Capecitabine for the oral treatment of metastatic breast cancer.

about

Capecitabine for the oral treatment of metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q43267032

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Capecitabine for the oral treatment of metastatic breast cancer.

@en

Capecitabine for the oral treatment of metastatic breast cancer.

@nl

type

Item

label

Capecitabine for the oral treatment of metastatic breast cancer.

@en

Capecitabine for the oral treatment of metastatic breast cancer.

@nl

prefLabel

Capecitabine for the oral treatment of metastatic breast cancer.

@en

Capecitabine for the oral treatment of metastatic breast cancer.

@nl

P1476

Capecitabine for the oral treatment of metastatic breast cancer.

@en

P2093

Hernán Cortés-Funes

http://www.w3.org/2001/XMLSchema#string

P2860

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Severe non-haematological toxicity after treatment with gemcitabine

Cancer statistics, 2004

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours.

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane.

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patients.

Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer.

Oral vinorelbine plus capecitabine (oral vincap) combination in patients with advanced breast cancer (ABC). A phase II study of the GOIM (Gruppo Oncologico dell'Italia Meridionale).

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine.

P304

805-817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17455057.2.6.805

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19803998

http://www.w3.org/2001/XMLSchema#string